highly significantP < 0.001
Improvement remained highly significant ( P < 0.001) for dryness, dyspareunia, and burning) at the 6-month follow up.
Improvement remained highly significant ( P < 0.001) for dryness, dyspareunia, and burning) at the 6-month follow up.